{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:23:58Z","timestamp":1771050238360,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.vaccine.2015.07.051","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:09:21Z","timestamp":1438214961000},"page":"4892-4900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single\u2013dose influenza vaccine protection"],"prefix":"10.1016","volume":"33","author":[{"given":"Yoshikazu","family":"Honda-Okubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Hao","family":"Ong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Nov (5)","key":"10.1016\/j.vaccine.2015.07.051_bib0220","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1542\/peds.2013-1493","article-title":"Influenza-associated pediatric deaths in the United States, 2004\u20132012","volume":"132","author":"Wong","year":"2013","journal-title":"Pediatrics"},{"issue":"Dec (Suppl 2)","key":"10.1016\/j.vaccine.2015.07.051_bib0225","first-page":"vii-S116","article-title":"Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002","volume":"28","author":"Brotherton","year":"2004","journal-title":"Commun Dis Intell"},{"issue":"Nov (10)","key":"10.1016\/j.vaccine.2015.07.051_bib0230","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1086\/656740","article-title":"The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong","volume":"51","author":"Wu","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Feb (1)","key":"10.1016\/j.vaccine.2015.07.051_bib0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MOP.0b013e32832185af","article-title":"Update on universal annual influenza immunization recommendations for children","volume":"21","author":"Bekker","year":"2009","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.vaccine.2015.07.051_bib0240","first-page":"CD004879","article-title":"Vaccines for preventing influenza in healthy children","volume":"2","author":"Jefferson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"11 Suppl","key":"10.1016\/j.vaccine.2015.07.051_bib0245","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/INF.0b013e31818a545d","article-title":"Emerging data on the safety and efficacy of influenza vaccines in children","volume":"27","author":"Vesikari","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"Nov (46)","key":"10.1016\/j.vaccine.2015.07.051_bib0250","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2013.09.005","article-title":"The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged \u22656 months to <36 months: a comparison of published and unpublished studies","volume":"31","author":"Kaczmarek","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.07.051_bib0255","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/141.2.258","article-title":"Influenza immunization policies and practices in Japan","volume":"141","author":"Dowdle","year":"1980","journal-title":"J Infect Dis"},{"issue":"Aug (31)","key":"10.1016\/j.vaccine.2015.07.051_bib0260","first-page":"989","article-title":"Update: recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010\u201311","volume":"59","author":"ACIP","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Sep (37)","key":"10.1016\/j.vaccine.2015.07.051_bib0265","first-page":"1","article-title":"Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010","volume":"15","author":"Kelly","year":"2010","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.vaccine.2015.07.051_bib0270","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS ONE"},{"issue":"Oct (46)","key":"10.1016\/j.vaccine.2015.07.051_bib0275","doi-asserted-by":"crossref","first-page":"6146","DOI":"10.1016\/j.vaccine.2014.08.068","article-title":"Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children","volume":"32","author":"Nolan","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.07.051_bib0280","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/glycob\/cwq201","article-title":"Delta inulin: a novel, immunologically active, stable packing structure comprising beta-d-[2\u22651] poly(fructo-furanosyl) alpha-d-glucose polymers","volume":"21","author":"Cooper","year":"2011","journal-title":"Glycobiology"},{"issue":"Jan (Pt 1)","key":"10.1016\/j.vaccine.2015.07.051_bib0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1099\/vir.0.023242-0","article-title":"Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations","volume":"92","author":"Cristillo","year":"2011","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.051_bib0290","first-page":"35","article-title":"Improving the dromedary antibody response: the hunt for the ideal camel adjuvant","volume":"18","author":"Eckersley","year":"2011","journal-title":"J Camel Pract Res"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.051_bib0295","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/CVI.00019-14","article-title":"Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvant","volume":"21","author":"Feinen","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"Apr (8)","key":"10.1016\/j.vaccine.2015.07.051_bib0300","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8+ T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J Virol"},{"issue":"Jun (Pt 6)","key":"10.1016\/j.vaccine.2015.07.051_bib0305","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1099\/vir.0.019190-0","article-title":"An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses","volume":"91","author":"Lobigs","year":"2010","journal-title":"J Gen Virol"},{"issue":"Sep (18)","key":"10.1016\/j.vaccine.2015.07.051_bib0310","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"87","author":"Petrovsky","year":"2013","journal-title":"J Virol"},{"issue":"Mar (12)","key":"10.1016\/j.vaccine.2015.07.051_bib0315","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2015.01.062","article-title":"A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax delta inulin adjuvant induces robust T-cell protection against listeria infection","volume":"33","author":"Rodriguez-Del Rio","year":"2015","journal-title":"Vaccine"},{"issue":"Apr (15)","key":"10.1016\/j.vaccine.2015.07.051_bib0320","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.vaccine.2012.12.077","article-title":"A novel hepatitis B vaccine containing Advax, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing","volume":"31","author":"Saade","year":"2013","journal-title":"Vaccine"},{"issue":"Aug (36)","key":"10.1016\/j.vaccine.2015.07.051_bib0325","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"issue":"Aug (36)","key":"10.1016\/j.vaccine.2015.07.051_bib0330","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1016\/j.vaccine.2014.06.057","article-title":"A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax) overcomes pregnancy-associated immune suppression and enhances passive neonatal protection","volume":"32","author":"Honda-Okubo","year":"2014","journal-title":"Vaccine"},{"issue":"Aug (37)","key":"10.1016\/j.vaccine.2015.07.051_bib0335","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.vaccine.2011.06.078","article-title":"Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets","volume":"29","author":"Layton","year":"2011","journal-title":"Vaccine"},{"issue":"Aug (36)","key":"10.1016\/j.vaccine.2015.07.051_bib0340","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1016\/j.vaccine.2012.06.009","article-title":"Randomized clinical trial of immunogenicity and safety of a recombinant H1N1\/2009 pandemic influenza vaccine containing Advax polysaccharide adjuvant","volume":"30","author":"Gordon","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.07.051_bib0345","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/eji.1830261118","article-title":"Partial correction of the TH2\/TH1 imbalance in neonatal murine responses to vaccine antigens through selective adjuvant effects","volume":"26","author":"Barrios","year":"1996","journal-title":"Eur J Immunol"},{"issue":"Aug (3)","key":"10.1016\/j.vaccine.2015.07.051_bib0350","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4049\/jimmunol.1203288","article-title":"Neonatal follicular Th cell responses are impaired and modulated by IL-4","volume":"191","author":"Debock","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2015.07.051_bib0355","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/08830189609061756","article-title":"Immunoglobulin deficient mice generated by gene targeting as models for studying the immune response","volume":"13","author":"Bot","year":"1996","journal-title":"Int Rev Immunol"},{"issue":"Aug (16)","key":"10.1016\/j.vaccine.2015.07.051_bib0360","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1128\/JVI.00327-14","article-title":"An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice","volume":"88","author":"Khalil","year":"2014","journal-title":"J Virol"},{"issue":"Mar (6)","key":"10.1016\/j.vaccine.2015.07.051_bib0365","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.170.6.2824","article-title":"Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens","volume":"170","author":"Pihlgren","year":"2003","journal-title":"J Immunol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2015.07.051_bib0370","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.4049\/jimmunol.1402071","article-title":"MF59 mediates its B Cell adjuvanticity by promoting T follicular helper Cells and thus germinal center responses in adult and early life","volume":"194","author":"Mastelic Gavillet","year":"2015","journal-title":"J Immunol"},{"issue":"Sep (5)","key":"10.1016\/j.vaccine.2015.07.051_bib0375","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.4049\/jimmunol.0903075","article-title":"The migration of T cells in response to influenza virus is altered in neonatal mice","volume":"185","author":"Lines","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2015.07.051_bib0380","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/eji.200636945","article-title":"Neonatal CD8+ T cells are slow to develop into lytic effectors after HSV infection in vivo","volume":"38","author":"Fernandez","year":"2008","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2015.07.051_bib0385","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.1201143","article-title":"Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvants","volume":"189","author":"Mastelic","year":"2012","journal-title":"J Immunol"},{"issue":"Aug (3)","key":"10.1016\/j.vaccine.2015.07.051_bib0390","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.4049\/jimmunol.1200761","article-title":"The adjuvant LT-K63 can restore delayed maturation of follicular dendritic cells and poor persistence of both protein- and polysaccharide-specific antibody-secreting cells in neonatal mice","volume":"189","author":"Bjarnarson","year":"2012","journal-title":"J Immunol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2015.07.051_bib0395","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.160.9.4217","article-title":"Newborn mice develop balanced Th1\/Th2 primary effector responses in vivo but are biased to Th2 secondary responses","volume":"160","author":"Adkins","year":"1998","journal-title":"J Immunol"},{"issue":"Sep (10)","key":"10.1016\/j.vaccine.2015.07.051_bib0400","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1084\/jem.20071371","article-title":"Delayed maturation of an IL-12-producing dendritic cell subset explains the early Th2 bias in neonatal immunity","volume":"205","author":"Lee","year":"2008","journal-title":"J Exp Med"},{"issue":"Feb (3)","key":"10.1016\/j.vaccine.2015.07.051_bib0405","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.166.3.2141","article-title":"Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes","volume":"166","author":"Goriely","year":"2001","journal-title":"J Immunol"},{"issue":"Mar (6)","key":"10.1016\/j.vaccine.2015.07.051_bib0410","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J Virol"},{"issue":"Jun (6)","key":"10.1016\/j.vaccine.2015.07.051_bib0415","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1189\/jlb.1012498","article-title":"IL-4Ralpha on CD4+ T cells plays a pathogenic role in respiratory syncytial virus reinfection in mice infected initially as neonates","volume":"93","author":"You","year":"2013","journal-title":"J Leukoc Biol"},{"issue":"Sep (27)","key":"10.1016\/j.vaccine.2015.07.051_bib0420","article-title":"Immunogenicity and safety of Advax, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled phase 1 study","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"issue":"Jun (3)","key":"10.1016\/j.vaccine.2015.07.051_bib0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4196\/kjpp.2014.18.3.225","article-title":"The protective role of TLR3 and TLR9 ligands in human pharyngeal epithelial cells infected with influenza A virus","volume":"18","author":"Han","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"issue":"Apr (17)","key":"10.1016\/j.vaccine.2015.07.051_bib0430","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.vaccine.2014.01.082","article-title":"The effects of administration of ligands for Toll-like receptor 4 and 21 against Marek's disease in chickens","volume":"32","author":"Parvizi","year":"2014","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010129?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15010129?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T17:00:24Z","timestamp":1691859624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15010129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":43,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0264410X15010129"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single\u2013dose influenza vaccine protection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}